Developed by the notable team of clinicians at the Front Line COVID-19 Critical Care (FLCCC) Alliance, the I-RECOVER protocol was developed in collaboration with expert clinicians including Dr. Paul Marik, Dr. Pierre Kory, Dr. Keith Berkowitz, and others to address the lingering issues associated with long haul COVID syndrome (LHCS).1
Also known as long-haulers syndrome and post-acute COVID-19 syndrome (PACS), this novel disorder presents with what can be a dizzying array of chronic and often-debilitating symptoms. Many of the issues involve neurological processes, and can include brain fog and cognitive impairments, headaches, loss of smell or taste, sleep difficulties, fatigue, and more. Symptoms are estimated to affect from roughly 10% to possibly 80% of COVID patients, many of whom only experienced mild infections, which adds to the difficulty in ascertaining the reasons it occurs and how to treat.
The I-RECOVER protocol draws upon the wealth of data compiled by the FLCCC physicians since the early days of the pandemic. While the approaches were initially empiric, the observed results from a combination of therapies facilitated by participating doctors led the team to devise a multimodal protocol based on the pathophysiology of the virus; additionally, they have noted success in treating post-vaccine inflammatory syndromes.
It’s important to remember that like all information and subsequent recommendations for treating long COVID, new data may precipitate changes to therapeutic recommendations. The ever-evolving health events require continual monitoring and updating as additional insight is acquired so any protocol for treatment may be subject to revision based on individual patient health and any other conditions. It is further advised that only those practitioners with experience in treating long-haulers syndrome should utilize this or similar protocols.
Here is a hyperlink to the full text at https://covid19criticalcare.com/wp-content/uploads/2021/06/FLCCC-Alliance-I-RECOVER-Management-Protocol-for-Long-Haul-COVID-19-Syndrome.pdf
Or click on the icon to view/download the entire file:
More about the FLCCC Alliance.
The Alliance represents the combined knowledge and expertise of physicians, nurses, and researchers in diverse fields of medicine and from all over the world. Formed by leading critical care specialists in March 2020, the FLCCC is now a 501(c)(3) non-profit organization dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients who are or become ill with the disease.
The FLCCC Alliance welcomes as members clinicians, other healthcare professionals, hospitals, and health-based organizations that use or support the FLCCC’s prophylactic, outpatient, or hospital treatment protocols for COVID-19. You can visit their site for additional information regarding membership or if you have other organization questions.
For additional reading in our long COVID series, please see:
What is long COVID?
The neurological and other symptoms of long COVID.
Why does long COVID occur?
If you have urgent concerns or symptoms, always consult your physician for guidance or contact an emergency medical provider at the earliest opportunity. For questions related to this and other articles on our website, or if you would like more information, please contact our offices to schedule an appointment.
In health and hope,
Dr. Suzanne Gazda
1 Front Line COVID-19 Critical Care Alliance